skip to main content

Lifelong ULT in Gout — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

EasyCrystal ArthropathyLifelong ULT in GoutSCE Rheumatology

A 55-year-old man with gout has achieved his serum urate target (<300 micromol/L) on Allopurinol 400 mg daily. He has been flare-free for 18 months. His tophi have completely dissolved. Can Allopurinol be stopped?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Gout is a lifelong condition requiring lifelong ULT in most patients; stopping ULT typically leads to serum urate rise crystal reformation and gout recurrence though the dose may be cautiously reduced once tophi have dissolved

Gout is a chronic metabolic condition and ULT is typically lifelong. BSR 2017 guidelines recommend that once tophi have dissolved the serum urate target may be relaxed from <300 micromol/L to <360 micromol/L (allowing possible dose reduction) but ULT should generally continue. Stopping ULT typically leads to serum urate rising above the saturation point crystal reformation and eventual gout recurrence. Patient education about the lifelong nature of ULT is essential for treatment adherence which remains the greatest challenge in gout management. NICE 2022 recommends annual serum urate monitoring after achieving target.

Reference: BSR 2017 gout guidelines; NICE NG219 (2022)